Spiegel Lab
Unlocking the Potential of Organic Synthesis. Solving the Challenges of Human Disease.
Pursuing New Frontiers
in Scientific Research
to Improve the Understanding and Treatment of Disease
The Spiegel Research Group is at the forefront of innovation in translating the potential of Organic Chemistry and Chemical Biology into novel approaches that solve the challenges of human disease.
​
We are dedicated to unlocking the promise of fundamental science to identify new “druggable” targets for treating disease. Our work jumpstarts drug development, providing our industry partners with the foundation to turn groundbreaking discoveries into life-changing new medicines.
Our work is a catalyst for the development of life-saving new medicines for waiting patients. By conducting research that gets drug developers the answers they need to move scientific discoveries forward to clinical development with greater speed and efficiency, our team makes vital contributions to the advancement of human health.
